The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
One Health-based surveillance model to focus on bird sanctuaries and high-risk human populations
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
The approval is backed by results from Lilly’s ATTAIN clinical trial program, which showed significant weight loss among participants
The construction projects, which have already begun, will be finalised gradually from the end of 2027 through 202
The agreement will see the two companies jointly develop and commercialise premium nutraceutical ingredients in advanced transdermal delivery formats
The pharmaceutical giant said it would pursue legal and regulatory action following Hims & Hers
The approval introduces a needle-free alternative to injectable GLP-1 therapies
Wegovy pill showed a mean weight loss of 16.6% in the OASIS 4 trial
Subscribe To Our Newsletter & Stay Updated
